Skip to main content
main-content

Free registration

Medicine Matters was developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

04-19-2018 | Older adults | News

Glycemic variability modifies mortality risk in older diabetes patients

The excess mortality risk associated with high or very low glycated hemoglobin values is modified by glycemic variability in diabetes patients aged 70 years or more, shows an analysis of The Health Improvement Network database.

02-23-2018 | Insulin | Practical approach | Article

Insulin matters: A practical approach to basal insulin management in type 2 diabetes

Experts review the evidence and best clinical practices of initiating and titrating insulin in patients with type 2 diabetes and provide guidance and practical recommendations for the healthcare community.

03-28-2018 | Devices and technology | View from the clinic | Article

Managing patient expectations for glucose management via a device

As the utility and availability of devices surges, so too do patient expectations. Prof. Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles.

Latest from across the site

04-19-2018 | Older adults | News

Glycemic variability modifies mortality risk in older diabetes patients

The excess mortality risk associated with high or very low glycated hemoglobin values is modified by glycemic variability in diabetes patients aged 70 years or more, shows an analysis of The Health Improvement Network database.

Source:

Lancet Diabetes Endocrinol 2018; Advance online publication

04-18-2018 | Artificial pancreas systems | News

Data support artificial pancreas for type 1 diabetes, but better evidence needed

Analysis of the research to date comparing artificial pancreas treatment with other insulin systems supports its ability to significantly improve glycemic control in patients with type 1 diabetes, while reducing the burden of hypoglycemia.

Source:

BMJ 2018; 361: k1310, k1613

04-18-2018 | Nephropathy | News

Neprilysin inhibition appears beneficial in diabetic kidney disease

Secondary analysis of the PARADIGM-HF trial shows that the adverse effects of diabetes on kidney function can be ameliorated by a neprilysin inhibitor.

Source:

Lancet Diabetes Endocrinol 2018; Advance online publication

04-18-2018 | Continuous glucose monitoring | News

CGM may be cost-effective in type 1 diabetes

Analysis of the DIAMOND study shows that continuous glucose monitoring in patients with type 1 diabetes could be considered cost-effective, although this depends on the value for money threshold used.

Source:

Diabetes Care 2018; Advance online publication

04-17-2018 | Medications | News

Modern antidiabetic medications ranked for survival benefits

A network meta-analysis published in JAMA offers indirect comparisons of the survival benefits associated with use of the most recent antidiabetic agents.

Source:

JAMA 2018; 319: 1580–1591

04-17-2018 | Dipeptidyl peptidase-4 inhibitors | At a glance | Article

Round up of the DPP-4 inhibitor CV outcome trials

medwireNews provides a brief overview of the published and ongoing dipeptidyl peptidase-4 inhibitorscardiovascular outcomes trials.

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John Wilding

New Content Item Meet our Advisory Board

image credits